A simple screening assay for substance affecting lymphocyte reactivity

1976 ◽  
Vol 12 (1-2) ◽  
pp. 141-147 ◽  
Author(s):  
John L. Pauly
2008 ◽  
Vol 42 (2) ◽  
pp. 186-189 ◽  
Author(s):  
Ornpreya Suptawiwat ◽  
Alita Kongchanagul ◽  
Wisoot Chan-It ◽  
Arunee Thitithanyanont ◽  
Witawat Wiriyarat ◽  
...  

2020 ◽  
Author(s):  
Manthan Patel ◽  
Divyesh Patel ◽  
Subhamoy Datta ◽  
Umashankar Singh

ABSTRACTThe antineoplastic agent Givinostat inhibits histone deacetylases. We present here our finding that the DNA-binding of human CGGBP1 is also inhibited by Givinostat. CGGBP1, a DNA-binding protein, is required for cancer cell proliferation. In our quest to exploit the potential anti-proliferative effects of CGGBP1 inhibition, we have developed a simple screening assay to identify chemical inhibitors of DNA-protein interactions. We have applied this screen for human CGGBP1 on a library of 1685 compounds and found that Givinostat is a direct inhibitor of CGGBP1-DNA interaction. The mechanism of action of Givinostat should thus extend beyond HDACs to include the inhibition of the myriad functions of CGGBP1 that depend on its binding to the DNA.


2020 ◽  
Author(s):  
Manthan Patel ◽  
Divyesh Patel ◽  
Subhamoy Datta ◽  
Umashankar Singh

Abstract The antineoplastic agent Givinostat inhibits histone deacetylases. We present here our finding that the DNA-binding of human CGGBP1 is also inhibited by Givinostat. CGGBP1, a DNA-binding protein, is required for cancer cell proliferation. In our quest to exploit the potential anti-proliferative effects of CGGBP1 inhibition, we have developed a simple screening assay to identify chemical inhibitors of DNA-protein interactions. We have applied this screen for human CGGBP1 on a library of 1685 compounds and found that Givinostat is a direct inhibitor of CGGBP1-DNA interaction. The mechanism of action of Givinostat should thus extend beyond HDACs to include the inhibition of the myriad functions of CGGBP1 that depend on its binding to the DNA.


2000 ◽  
Vol 97 (4) ◽  
pp. 231-237 ◽  
Author(s):  
Thomas W Stief ◽  
Frauke Hinz ◽  
Jürgen Kurz ◽  
Manfred O Doss ◽  
Volker Kretschmer

2020 ◽  
Vol 25 (4) ◽  
pp. 165-169
Author(s):  
Elisabet Sjöberg Wester ◽  
Julia Gustafsson ◽  
Beverly Snell ◽  
Peggy Spruell ◽  
Åsa Hellberg ◽  
...  

2020 ◽  
Author(s):  
Manthan Patel ◽  
Divyesh Patel ◽  
Subhamoy Datta ◽  
Umashankar Singh

Abstract The antineoplastic agent Givinostat inhibits histone deacetylases. We present here our finding that the DNA-binding of human CGGBP1 is also inhibited by Givinostat. CGGBP1, a DNA-binding protein, is required for cancer cell proliferation. In our quest to exploit the potential anti-proliferative effects of CGGBP1 inhibition, we have developed a simple screening assay to identify chemical inhibitors of DNA-protein interactions. We have applied this screen for human CGGBP1 on a library of 1685 compounds and found that Givinostat is a direct inhibitor of CGGBP1-DNA interaction. The mechanism of action of Givinostat should thus extend beyond HDACs to include the inhibition of the myriad functions of CGGBP1 that depend on its binding to the DNA.


2010 ◽  
Vol 43 (10-11) ◽  
pp. 1746-1755 ◽  
Author(s):  
Alice Zitova ◽  
Fiach C. O'Mahony ◽  
Ilya N. Kurochkin ◽  
Dmitri B. Papkovsky

1995 ◽  
Vol 79 (2) ◽  
pp. 217-222 ◽  
Author(s):  
Michael Kraus ◽  
Michael Noah ◽  
Karl Fickenscher

Sign in / Sign up

Export Citation Format

Share Document